Nanotechnological strategies for treatment of leishmaniasis—a review
L De Almeida, AT Fujimura, MLD Cistia… - Journal of …, 2017 - ingentaconnect.com
The World Health Organization (WHO) estimates that more than one billion people suffer
from neglected tropical diseases. Leishmaniasis is a widespread disease, affecting 12 …
from neglected tropical diseases. Leishmaniasis is a widespread disease, affecting 12 …
New approaches from nanomedicine for treating leishmaniasis
V Gutiérrez, AB Seabra, RM Reguera… - Chemical Society …, 2016 - pubs.rsc.org
Leishmaniasis, a vector-borne disease caused by obligate intramacrophage protozoa,
threatens 350 million people in 98 countries around the world. There are already 12 million …
threatens 350 million people in 98 countries around the world. There are already 12 million …
Recent advances in nanosystems and strategies for managing leishmaniasis
R Vaghela, PK Kulkarni, RAM Osmani… - Current drug …, 2017 - ingentaconnect.com
Background: Parasitic infection such as leishmaniasis, a neglected tropical disease,
presents a significant global burden which is responsible for high mortality rate especially in …
presents a significant global burden which is responsible for high mortality rate especially in …
Application of nanotechnology in treatment of leishmaniasis: a review
Leishmaniasis is a neglected tropical disease caused by a protozoan species of the genus
Leishmania affecting mostly the developing countries. The disease with current mortality rate …
Leishmania affecting mostly the developing countries. The disease with current mortality rate …
Promising nanotherapy in treating leishmaniasis
A de Souza, DSS Marins, SL Mathias… - International Journal of …, 2018 - Elsevier
Leishmaniases are infectious diseases caused by an intracellular protozoan in humans by
20 different species of Leishmania among more than 53 species. There are at least twelve …
20 different species of Leishmania among more than 53 species. There are at least twelve …
Nanomedicines for therapy of visceral leishmaniasis
Visceral leishmaniasis (VL) or kala-azar is a vector borne infectious disease caused by the
protozoan parasites of the genus Leishmania. VL is endemic in more than 85 countries with …
protozoan parasites of the genus Leishmania. VL is endemic in more than 85 countries with …
Nanostructured delivery systems with improved leishmanicidal activity: a critical review
N Bruni, B Stella, L Giraudo, C Della Pepa… - International journal …, 2017 - Taylor & Francis
Leishmaniasis is a vector-borne zoonotic disease caused by protozoan parasites of the
genus Leishmania, which are responsible for numerous clinical manifestations, such as …
genus Leishmania, which are responsible for numerous clinical manifestations, such as …
Innovative solutions for the control of leishmaniases: nanoscale drug delivery systems
V Wagner, A Minguez-Menendez… - Current …, 2019 - ingentaconnect.com
Background: Leishmania are sandfly-transmitted protozoan parasites that harbour within the
macrophages of a mammalian host and cause leishmaniasis, a serious zoonotic disease …
macrophages of a mammalian host and cause leishmaniasis, a serious zoonotic disease …
A systematic review of drug-carrying nanosystems used in the treatment of Leishmaniasis
C Registre, RDOA Soares, KTS Rubio… - ACS Infectious …, 2023 - ACS Publications
Leishmaniasis is an infectious disease responsible for a huge rate of morbidity and mortality
in humans. Chemotherapy consists of the use of pentavalent antimonial, amphotericin B …
in humans. Chemotherapy consists of the use of pentavalent antimonial, amphotericin B …
[PDF][PDF] NANOMEDICINE AND LEISHMANIASIS: FUTURE PROSPECTS.
The increasing incidences of leishmaniasis due to toxicity and resistance of drug as a result
of high drug dose and its spreading to newer areas needt to develop newer drugs for its …
of high drug dose and its spreading to newer areas needt to develop newer drugs for its …